Cytochrome P450 genotype and aggressive behavior on selective serotonin reuptake inhibitors-Reference-Cited by-同舟云学术

Cytochrome P450 genotype and aggressive behavior on selective serotonin reuptake inhibitors

Published:2018-09-01 Issue:14 Volume:19 Page:1097-1099
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Ekhart Corine¹,Matic Maja²,Kant Agnes¹,Elens Laure³,Puijenbroek Eugène van¹⁴,Schaik Ron van²

Affiliation:

1. Netherlands Pharmacovigilance Centre Lareb, Den Bosch, The Netherlands

2. Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, The Netherlands

3. Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium; Louvain centre for Toxicology & Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et clinique (IREC), Université catholique de Louvain, Brussels, Belgium

4. Department of Pharmacotherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands

Abstract

Letter in reply to: Eikelenboom-Schieveld SJM, Fogleman JC. Letter to the Editor. Pharmcogenomics 19(14), 1095–1096 (2018) [ 1 ]. Regarding: Ekhart, Matic M, Kant A, van Puijenbroek E, van Schaik R. CYP450 genotype and aggressive behavior on selective serotonin reuptake inhibitors. Phamacogenomics 18(7), 613–620 (2017) [ 2 ].

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2018-0122

Reference5 articles.

1. Letter to the Editor

2. CYP450 genotype and aggressive behavior on selective serotonin reuptake inhibitors

3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

4. Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects